# Citrus Bergamot Lipid Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/citrus-bergamot-lipid-randomized-trial-evidence-review
Category: evidence-review
Summary: Citrus Bergamot Lipid Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are 
Last reviewed: 2026-06-25
Reviewed by: Migaku Evidence Review
# Citrus Bergamot Lipid Randomized Trial: What the Evidence Says

## Quick Answer

Citrus Bergamot Lipid Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Effect of Citrus bergamia Supplementation on Body Composition in Humans: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials | systematic review | 1 | 2026-01-22 | 10.1111/obr.70094 |
| Advances in Nutrition for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management: Current Perspectives from the Bench to the Bedside. | research article | 4 | 2026-05-27 | 10.3390/nu18111708 |

## What The Sources Report

- Obesity is a multifactorial disease defined as abnormal or excessive fat accumulation that presents a risk to health because it is a major risk factor for several noncommunicable diseases (NCDs), such as cardiovascular diseases, diabetes, and several types of cancer. [Pujia Carmelo (2026); evidence level 1]
- Furthermore, obesity and its associated health problems have a significant economic impact on the global healthcare system. [Pujia Carmelo (2026); evidence level 1]
- Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), has emerged as the most prevalent chronic liver disease worldwide, with an overall global prevalence of 30% [...]. [Rodriguez-Ramiro I (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For citrus bergamot lipid randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Pujia Carmelo (2026). Effect of
Citrus bergamia
Supplementation on Body Composition in Humans: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. DOI: 10.1111/obr.70094. PMCID: PMC13243342. PMID: 41572527. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13243342/
- Rodriguez-Ramiro I (2026). Advances in Nutrition for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management: Current Perspectives from the Bench to the Bedside.. DOI: 10.3390/nu18111708. PMCID: PMC13258139. PMID: 42280351. https://pmc.ncbi.nlm.nih.gov/articles/PMC13258139/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.